Equine VEGF antibody and antigen (recombinant protein)

Diagnostic anti-Equine VEGF antibodies pairs and antigen for animal health (animal Equine/Horse angiogenesis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-EQU-VEGF-Ag01 Recombinant Equine VEGF protein 3090
GMP-EQU-VEGF-Ab01 Anti-Equine VEGF mouse monoclonal antibody (mAb) 1953
GMP-EQU-VEGF-Ab02 Anti-Equine VEGF mouse monoclonal antibody (mAb) 1953
GMP-EQU-VEGF-Ab03 Anti-Equine VEGF human monoclonal antibody (mAb) 1953
GMP-EQU-VEGF-Ab04 Anti-Equine VEGF human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-EQU-VEGF-Ag01
Product Name Recombinant Equine VEGF protein
Target/Biomarker Equine Vascular Endothelial Growth Factor ()
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Equine Vascular Endothelial Growth Factor antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of animal Equine/Horse with angiogenesis.
Tag His
Products description Recombinant Equine VEGF protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-VEGF-Ab01, GMP-EQU-VEGF-Ab02
Product Name Anti-Equine VEGF mouse monoclonal antibody (mAb)
Target/Biomarker Equine Vascular Endothelial Growth Factor ()
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Equine Vascular Endothelial Growth Factor antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies in level test of animal Equine/Horse with angiogenesis.
Tag mFc
Products description Anti-Equine VEGF mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-VEGF-Ab03, GMP-EQU-VEGF-Ab04
Product Name Anti-Equine VEGF human monoclonal antibody (mAb)
Target/Biomarker Equine Vascular Endothelial Growth Factor ()
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Equine Vascular Endothelial Growth Factor antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies in level test of animal Equine/Horse with angiogenesis.
Tag hFc
Products description Anti-Equine VEGF human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Equine Vascular Endothelial Growth Factor (eVEGF) occupies a pivotal position in the intricate web of equine physiology, serving as a guardian of vascular health and orchestrator of angiogenesis—the creation of new blood vessels from existing ones. Encoded by the VEGF-A gene, eVEGF comes in several isoforms, each meticulously designed to engage with specific receptors, ensuring precise control over angiogenesis in horses. At its core, eVEGF is a glycoprotein primarily expressed in endothelial cells, which line the inner walls of blood vessels. Its primary mission is to initiate and regulate angiogenesis—a dynamic and finely-tuned process that plays a critical role in various aspects of equine life. During embryonic development, eVEGF steers the formation of the intricate vascular network required to nourish the developing equine fetus. In adulthood, it remains an unwavering ally, promoting the growth of new blood vessels at the site of injuries, ensuring efficient tissue repair. Additionally, eVEGF plays a pivotal role in maintaining proper vascularization of the uterus during equine pregnancies, providing a nurturing environment for the developing foal.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment